MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Mitochondrial DNA(mtDNA)"

  • 2026 International Congress

    POLG-Related Disease Mimicking Progressive Supranuclear Palsy with Selective Vertical Gaze Restriction

    E. Orozco, W. Wagrees, C. Hainline, G. Suarez-Cedeno (Albuquerque, USA)

    Objective: To describe a patient with a pathogenic POLG mutation presenting with sensory neuropathy, ataxia, recurrent falls, and supranuclear gaze palsy initially misdiagnosed as progressive…
  • 2026 International Congress

    Adolescent-onset Myoclonus Dystonia in MT-ND6 m.14487T>C–Associated Leigh Syndrome

    Y. Nishonova, S. Shokirov, I. Mazunin, O. Turgunkhujaev (Tashkent, Uzbekistan)

    Objective: To describe the clinical and genetic features of an adolescent patient with MT-ND6-associated Leigh syndrome presenting with a prominent dystonia and myoclonus. Background: Leigh…
  • 2026 International Congress

    Association of MT-ATP6 Polymorphisms with Increased Reactive Oxygen Species and Biomarker Alterations in Parkinson’s Disease

    B. Chandar, HSB. Suresh Babu, NR. Raj, MB. Balachandar, VL. Lakhanpal (Bathinda, India)

    Objective: To evaluate the association between MT-ATP6 gene polymorphisms, oxidative stress, and biomarker alterations in PD patients from Indian populaiton Background: Mitochondrial dysfunction and oxidative…
  • 2026 International Congress

    The Landscape of Movement Disorders in Mitochondrial Aminoacyl t-RNA Synthetase Disorders: A Case Series

    SRC. Roychowdhury, HA. Alfaris, SY. Yoganathan, AM. Menetrey, LMV. M. Vogt, RA. Alayed, LLM. Leblanc-Millar, DC. Cordeiro, LA. Aljouda, CG. Gorodetsky (Delhi, India)

    Objective: To characterize the movement disorder spectrum in mitochondrial aminoacyl-tRNA synthetase (m-aaRS)defects. Background: m-aaRS disorders are an increasingly recognized genetic conditions demonstrating marked phenotypic pleiotropy,…
  • 2026 International Congress

    Single-Neuron Analysis of Mitochondrial DNA Alterations and Respiratory Chain Dysfunction in Parkinson’s Disease

    A. Rubiolo, S. Geithus, S. Mostafavi, C. Dölle, I. Flønes, C. Tzoulis (Bergen, Norway)

    Objective: To investigate mitochondrial DNA (mtDNA) alterations in single neurons from Parkinson's disease (PD) brains and determine their relationship with respiratory chain deficiency. Background: Mitochondrial dysfunction,…
  • 2025 International Congress

    Assessment of mitochondrial DNA copy number and common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2

    LE. Almaguer Mederos, D. Cuello Almarales, R. Aguilera Rodríguez, D. Almaguer Gotay, DO. Palenzuela Gardon, H. Camacho Rodríguez, A. Estupiñán Rodríguez, N. Canales Ochoa, S. Gispert, G. Auburger (Frankfurt am Main, Germany)

    Objective: Assessing the relevance of mtDNA copy number (mtDNAcn) and its common deletion (del4977) as candidate peripheral biomarkers for Spinocerebellar ataxia type 2 (SCA2). Background:…
  • 2025 International Congress

    The Role of Mitochondrial DNA Haplogroups in determining the Age of Onset in Indian SCA2 Patients.

    A. Sonakar, C. Sharma, S. Reza, S. Pandey, M. Srivastava, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: To investigate the contribution of mitochondrial DNA (mtDNA) haplogroups to the age at onset (AO) of Spinocerebellar Ataxia type 2 (SCA2) in Indian patients,…
  • 2025 International Congress

    Quercetin Reduces mtDNA Release in PRKN-Deficient and Oxidatively Stressed SH-SY5Y Cells

    G. Agyeah, J. Ghelfi, L. Gallucci, K. Wasner, P. Antony, A. Rakovic, S. Pereira, A. Grünewald (Belval Esch-sur-Alzette, Luxembourg)

    Objective: This study investigates the role of Parkin deficiency in mitochondrial dysfunction and its contribution to mitochondrial DNA (mtDNA) release in Parkinson’s disease (PD). We…
  • 2025 International Congress

    CSF Mitochondrial DNA Indicates Body Composition and Energy Metabolism in Parkinson’s Disease.

    Y. Mizutani, T. Nakai, Y. Maeda, R. Ohdake, R. Nagao, S. Shima, K. Kawabata, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)

    Objective: This study aimed to elucidate the associations between cerebrospinal fluid (CSF) cell-free mitochondrial DNA (cf-mtDNA) levels and body composition, nutritional status, and metabolic biomarkers…
  • 2025 International Congress

    Association of Mitochondrial DNA Haplogroup and pS65-Ub Levels in Lewy Body Disease

    N. Tran, X. Hou, M. Heckman, F. Fiesel, S. Koga, D. Dickson, W. Springer, O. Ross (Jacksonville, USA)

    Objective: To determine whether specific mitochondrial DNA (mtDNA) haplogroup(s) affect the level of p-S65-Ub as quantitative marker of mitochondrial damage in Lewy Body Disease. Background:…
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley